logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Kailash Cancer Hospital & Research Centre (KCHRC)

Verified
+912668265300
Source: Site record.
http://www.greenashram.org/contactus

Basic Information

Site Overview

Source: Human-provided.

Kailash Cancer Hospital & Research Centre is a well-established tertiary and quaternary cancer care institute located in Goraj, Taluka Waghodia, Vadodara District, Gujarat, India. Established in 2001, the centre was developed to address regional gaps in access to advanced oncology services and has expanded into a 450-bed modern cancer hospital offering comprehensive clinical care and research under one roof. The hospital provides multidisciplinary oncology services including medical oncology, surgical oncology, radiation oncology, nuclear medicine and supportive/palliative care, supported by cutting-edge diagnostics and treatment technologies. Its departments focus on personalized, patient-centric treatment plans, holistic supportive care, and integrated rehabilitation services. Kailash Cancer Hospital also operates high-quality diagnostic, pharmacy and blood bank services to support continuous patient care and participates in community outreach and clinical research initiatives to…

Source: Trial-derived.
12Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
5Active Trials
Source: Trial-derived.
5Completed Trials
Source: Trial-derived.
23Unique Conditions
Source: Trial-derived.
14Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Non-Small Cell Lung Cancer (2)Source: Trial-derived. Advanced Non-Small Cell Lung Cancer (1)Source: Trial-derived. Breast Cancer (1)Source: Trial-derived. Breast Neoplasms (1)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (1)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (NSCLC) (1)Source: Trial-derived. Early Breast Cancer (1)Source: Trial-derived. Fallopian Tube Neoplasms (1)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (2)Source: Trial-derived. Lambda Therapeutic Research Ltd. (2)Source: Trial-derived. Aurigene Discovery Technologies Limited (1)Source: Trial-derived. Ayana Pharma Ltd., (1)Source: Trial-derived. CanariaBio Inc. (1)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. Intas Pharmaceuticals, Ltd. (1)Source: Trial-derived. Janssen Research & Development, LLC (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase I
Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 41

Principal investigators

Source: Human-provided. 8

Study coordinators

Source: Human-provided. 9

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot